XLY.V - Auxly Cannabis Group Inc.

TSXV - TSXV Delayed Price. Currency in CAD
0.8800
0.0000 (0.00%)
As of 11:23AM EDT. Market open.
Stock chart is not supported by your current browser
Previous Close0.8800
Open0.8600
Bid0.8800 x 0
Ask0.8900 x 0
Day's Range0.8600 - 0.8800
52 Week Range0.6000 - 1.6200
Volume176,210
Avg. Volume1,722,041
Market Cap533.871M
Beta (3Y Monthly)8.79
PE Ratio (TTM)N/A
EPS (TTM)-0.1370
Earnings DateN/A
Forward Dividend & YieldN/A (N/A)
Ex-Dividend DateN/A
1y Target Est1.68
  • GlobeNewswire18 days ago

    Auxly Announces Receipt of Cultivation and Processing Licences for Robinsons Cannabis Facility

    Auxly Cannabis Group Inc. (TSX.V - XLY) ("Auxly" or the "Company") today announced that its wholly-owned subsidiary, Robinsons Cannabis Inc. (“Robinsons”), has been granted standard cultivation and processing licences by Health Canada pursuant to the Cannabis Act and Cannabis Regulations. The licences give Robinsons the ability to begin cultivation at its fully constructed 27,700 square-foot facility in Kentville, Nova Scotia, which was purpose-built to produce high-quality cannabis. Led by experienced head grower Andrew Robinson, Robinsons is uniquely positioned to capture the attention of luxury cannabis consumers, with operations built on a devotion to uncompromising quality and a premium cannabis experience.

  • GlobeNewswire28 days ago

    Auxly Reports Fourth Quarter and Full Year 2018 Financial Results and Provides Outlook for 2019

    Auxly Cannabis Group Inc. (XLY.V) (CBWTF) ("Auxly" or the "Company") today released its fourth quarter and full year 2018 financial results. The Company’s state-of-the-art processing facility at its wholly owned subsidiary Dosecann Inc. (“Dosecann”) and its highly-skilled team give the Company the ability to turn raw cannabis into derivative cannabis products.

  • GlobeNewswirelast month

    Auxly to Report 2018 Financial Results on March 29, 2019

    VANCOUVER, British Columbia, March 18, 2019 -- Auxly Cannabis Group Inc. (TSX.V - XLY) ("Auxly" or the "Company") today announced that it plans to report its fourth quarter and.

  • GlobeNewswire2 months ago

    Auxly Congratulates Streaming Partner Lotus Ventures on Obtaining Cannabis Licences From Health Canada

    Auxly Cannabis Group Inc. (TSX.V - XLY) ("Auxly" or the "Company") today announced that its streaming partner, Lotus Ventures Inc. (“Lotus”), has been granted a “standard cultivation” licence and a “sale for medical purposes” licence by Health Canada pursuant to the Cannabis Act and Cannabis Regulations. The licences give Lotus the ability to begin cultivation at its fully constructed 22,500 square-foot facility in Armstrong, British Columbia (the “Facility”). Hugo Alves, President of Auxly said: “We want to congratulate Dale, Stephen, Scott, Carl, Monica and the rest of the Lotus team on obtaining their Cannabis Act licences! This is an important step for Auxly as we continue to diversify our supply chain, utilizing a network of subsidiaries and partners to provide reliable sources of diverse raw product.

  • GlobeNewswire2 months ago

    Auxly Bolsters Management Team

    Auxly Cannabis Group Inc. (TSX.V - XLY) ("Auxly" or the "Company") is pleased to announce the appointments of Brian Schmitt as Chief Financial Officer, Jason Sonshine as Vice President, Strategy, and Carla Nawrocki as Vice President, Investor Relations of the Company. Brian Schmitt, CFO, is an accomplished finance and accounting executive with approximately 30 years of experience in both private and publicly-traded companies. Most recently, Mr. Schmitt acted as the CFO at EnerCare Inc., where during his tenure with the company he played a large part in growing the company through acquisition and helped carve out their strategy, systems integration and operating plan.

  • GlobeNewswire3 months ago

    Auxly Announces Termination of FSD Pharma Joint Venture

    Auxly Cannabis Group Inc. (TSX.V - XLY) ("Auxly" or the "Company") today announced the termination of the definitive agreement dated March 3, 2018 (the “Agreement”) between the Company and FV Pharma Inc., a wholly-owned subsidiary of FSD Pharma Inc. (“FSD Pharma”) (CSE:HUGE) governing the joint venture between the parties. The joint venture was formed with the intention of developing a portion of FSD Pharma's cannabis cultivation facility located in Cobourg, Ontario (the “JV Facility”) in mutually agreed staged phases (the “JV Facility Development”).

  • GlobeNewswire3 months ago

    Auxly Signs Definitive Agreement With Curative Cannabis

    Auxly Cannabis Group Inc. (XLY.V) (CBWTF) (the "Company") is pleased to announce that the Company has signed a definitive agreement (the “Transaction”) with 2368523 Ontario Limited (d/b/a) Curative Cannabis ("Curative"). The Company will acquire 46% of the common shares of Curative and enter into a long-term cannabis purchase and sale agreement to fund the construction and development costs of Curative’s cannabis cultivation facility in Chatham-Kent, Ontario (the “Facility”). The Facility is designed as a purpose-built indoor facility for the production of ultra-premium cannabis product.

  • GlobeNewswire3 months ago

    REPEAT - New Danish Cannabis Export Regulations Very Positive for ICC; Auxly Uruguay Distribution Partnership Moves Toward Commercialization

    VANCOUVER, British Columbia, Jan. 10, 2019 -- ICC International Cannabis Corp. (CSE: WRLD.U) (FWB: 8K51) (OTC: KNHBF) ("ICC" or “International Cannabis” or the “Company”) is.

  • TheStreet.com4 months ago

    Horizons Adds New Cannabis Stocks to Its ETFs

    After a difficult quarter for the marijuana sector, two of the most successful cannabis ETFs have added to their basket of stocks.

  • GlobeNewswire4 months ago

    Auxly Announces Completion of Inverell S.A. Acquisition

    Auxly Cannabis Group Inc. (XLY.V) (CBWTF) (the "Company") is pleased to announce that, further to its previous releases, it has completed the acquisition of 80% of the outstanding common shares (the “Transaction”) of Inverell S.A. (“Inverell”). The Transaction positions the Company as a leader in the global CBD economy with a highly efficient, low-cost source of cannabinoids for international distribution, including through the Company's strategic partnership with ICC International Cannabis Corporation Inc. (CSE:WRLD) which provides the Company with access to 16 markets through a network of 35,000 pharmacies.

  • Inner Spirit Holdings Provides December 2018 Sales Results, Year-End Highlights and 2019 Strategy Update
    CNW Group4 months ago

    Inner Spirit Holdings Provides December 2018 Sales Results, Year-End Highlights and 2019 Strategy Update

    CALGARY , Jan. 8, 2019 /CNW/ - Inner Spirit Holdings Ltd. ("Inner Spirit" or "the Company") (ISH.CN) today provided its December 2018 sales results, recapped its year-end highlights, and delivered a strategy update for 2019. Inner Spirit reported system-wide retail sales of $2,253,919 for the month of December.

  • GlobeNewswire4 months ago

    Auxly Strengthens Board of Directors Through the Appointment of Genevieve Young and Jean-Paul Gaillard as Independent Directors

    Auxly Cannabis Group Inc. (XLY.V) (CBWTF) ("Auxly" or the "Company") is pleased to announce the appointment of Genevieve Young and Jean-Paul Gaillard as independent members of its board of directors, effective immediately. Following the appointments, Auxly’s board will consist of five members, three of whom are independent from the Company. Genevieve Young is the President and Chief Operating Officer of Global Public Affairs, Canada’s leading privately held strategic communications and government advocacy consultancy representing some of Canada’s largest and most dynamic organizations.

  • GlobeNewswire5 months ago

    Auxly Congratulates Partner ICC International Cannabis Corp on Acquisition of Cannabis Genetics Company Green Gene Research Inc

    Auxly Cannabis Group Inc. (TSX.V - XLY) ("Auxly" or the "Company") is pleased to announce that its strategic international partner, ICC International Cannabis Corp. ("ICC") (CSE:WRLD), has entered into a definitive agreement to acquire all of the issued and outstanding shares of Green Gene Research Inc. (“Green Gene”), a cannabis genetics company with significant experience in cannabis research, testing, cultivation and the optimization of proprietary seeds and strains. In addition, Green Gene controls a portfolio of over 120 laboratory-tested unique cannabis strains carefully curated over the past 17 years of Green Gene’s operations. In connection with the strategic investment and commercial rights agreement announced on September 17, 2018, Auxly has become a preferred commercial partner to ICC on its current and future international and domestic cannabis ventures, including Green Gene, for a period of 10 years.

  • GlobeNewswire5 months ago

    Auxly Congratulates Partner ICC International Cannabis Corp on Acquisition of Portuguese Hemp Company

    Auxly Cannabis Group Inc. (TSX.V - XLY) ("Auxly" or the "Company") is pleased to announce that its strategic international partner, ICC International Cannabis Corp. ("ICC") (CSE:WRLD), has entered into a definitive agreement to acquire all issued and outstanding shares of Enigma Unipessoal Lda (“Enigma”). Enigma is a large-scale hemp operator based in Castelo Branco, Portugal with licenses to cultivate, extract, import, export and process hemp derived products on 400 acres of land. Having acquired one of the first hemp licenses to be issued in Portugal, Enigma successfully harvested its first crop in 2015 and is a notable importer of proprietary hemp seeds.

  • GlobeNewswire5 months ago

    Auxly Reports Q3 2018 Financial Results and Highlights Key Milestones

    Auxly Cannabis Group Inc. (TSX.V - XLY) (CBWTF) ("Auxly" or the "Company") has reported its financial and operational results for the three and nine months ended September 30th, 2018. Auxly’s management team has prioritized the following objectives for each of the Company’s business segments. Upstream: The Company continues to acquire cultivation capacity through the development of facilities in Canada and Uruguay.

  • GlobeNewswire6 months ago

    Auxly Announces Receipt of SENACLAFT Approval and Closing of Inverell S.A. Acquisition

    Auxly Cannabis Group Inc. (XLY.V) (CBWTF) ("Auxly" or the "Company") is pleased to announce that, further to the binding interim agreement announced on January 30th, 2018, the Company has received approval from the Secretaría Nacional para la Lucha contra el Lavado de Activos y el Financiamiento del Terrorismo (“SENACLAFT”), the government body overseeing foreign direct investments in Uruguay, for the Company’s acquisition of 80% of the issued and outstanding common shares (the “Transaction”) of Inverell S.A. (“Inverell”). Inverell is a federally licensed Cannabis Operator based in Montevideo, Uruguay. Led by Dr. Raúl Urbina, Inverell is a large-scale outdoor producer of hemp plants for CBD extraction operating on an initial footprint of approximately 300 hectares.

  • CNW Group7 months ago

    High Tide Congratulates FSD Pharma for Achieving $1 Billion Market Capitalization and Its Other Recent Successes

    CALGARY , Sept. 21, 2018 /CNW/ - High Tide Ventures Inc. ("High Tide" or the "Company") today announced that it congratulates FSD Pharma Inc. (CSE:HUGE) ("FSD Pharma") for achieving a $1 Billion market capitalization and its other recent successes. The Company would like to commend FSD Pharma on reaching such a significant valuation milestone in the Canadian cannabis market, which only a small number of other companies have been able to achieve.  Further, High Tide would also like to acknowledge the significance of FSD Pharma's recent receipt of $7.5 Million from Auxly Cannabis Group Inc. (XLY.V) ("Auxly"), at a premium to its recent market share price, to further fund construction of its 220,000 square foot cultivation facility in Cobourg, Ontario .

  • FSD Pharma Inc. Announces $7.5 Million Dollar at $1 Per Share Investment as Part of Existing Strategic Alliance with Auxly Cannabis Group Inc.
    CNW Group7 months ago

    FSD Pharma Inc. Announces $7.5 Million Dollar at $1 Per Share Investment as Part of Existing Strategic Alliance with Auxly Cannabis Group Inc.

    TORONTO , Sept. 20, 2018 /CNW/ - FSD Pharma Inc. ("FSD" or the "Company") (HUGE.CN) is pleased to announce that pursuant to the approved construction and development budget announced on July 3, 2018 (Link), Auxly Cannabis Group Inc. (TSX.V – XLY) ("Auxly") has made an equity investment into the Company at $1.00 per Class B Subordinate Voting Share for total proceeds of $7.5 million . The buildout of the Joint Cultivation Footprint is currently underway in Cobourg, Ontario and will include dedicated space for large scale extraction capabilities. In addition to the Joint Cultivation Footprint, FSD is also implementing several technological advancements at the Cobourg facility aimed at increasing energy efficiency and post-harvest process automation.

  • ACCESSWIRE7 months ago

    3 Canadian Marijuana Stocks Continuing to Trade Higher in September

    CORAL GABLES, FL / ACCESSWIRE / September 11, 2018 / Canadian marijuana stocks continue to lead the sector as the October deadline looms. In roughly 1 month Canada will begin legal sale of recreational marijuana across the country but this is just the beginning for the country. The move by Canada effectively makes the country the first G7 nation to legalize recreational cannabis use and further opens opportunities for companies in Canada to export marijuana as well.